Bioverativ Inc. is an American multinational biotechnology company that specializes in the discovery, development, and delivery of therapies for the treatment...
7 KB (469 words) - 14:03, 8 August 2024
Biogen (section Bioverativ)
hemophilia business, known as Bioverativ. The hemophilia business would become an independent publicly traded company. Bioverativ offered two hemophilia drugs...
48 KB (3,872 words) - 07:23, 31 August 2024
achievements. In January 2018, Sanofi announced that it would acquire Bioverativ for $11.6 billion and days later announced that it would acquire Ablynx...
91 KB (8,778 words) - 06:05, 10 August 2024
BioLineRx (2003– ) BioMarin (1997– ) bioMérieux (1963– ) BiondVax (2003– ) Bioverativ (2016– ) Biovista (2005– ) Bliss (1984– ) Bluepharma (1990s– ) Boehringer...
34 KB (2,168 words) - 15:30, 26 August 2024
from his alma mater in 2010. Harris was EVP of Research & Development at Bioverativ until it was acquired by Sanofi in 2018. From 2011 to 2016, He worked...
9 KB (883 words) - 10:47, 19 May 2024
Hersha Hospitality Trust to Join S&P SmallCap 600" (PDF). "LogMeIn and Bioverativ Set to Join the S&P MidCap 400; Others to Join S&P SmallCap 600" (PDF)...
254 KB (7,805 words) - 20:05, 22 August 2024
for haemophilia A. In its partnership with Pfizer in 2017, Sangamo uses Bioverativ in hemoglobinopathies such as beta thalassemia and sickle cell disease...
10 KB (855 words) - 04:44, 18 August 2024
43 2017 Gilead Sciences Kite Pharma Acquisition 11.9 15 44 2018 Sanofi Bioverativ Acquisition 11.6 14 45 2011 Gilead Sciences Pharmasset Acquisition 11...
30 KB (625 words) - 20:08, 6 February 2024
Tebentafusp Immunocore HLA-A*02:01–positive uveal melanoma Sutimlimab Bioverativ cold agglutinin disease Lutetium (177Lu) vipivotide tetraxetan Novartis...
34 KB (180 words) - 22:09, 8 April 2024
in response to cold and stress). This medication is being developed by Bioverativ, a Sanofi company. Sutimlimab was approved for medical use in the United...
13 KB (1,031 words) - 04:54, 24 February 2024